Summer Stock Update: Bancorp Inc., Xylem Inc., Vertex Pharmaceuticals,, and Novo Nordisk - The Hottest Picks for Savvy Investors

Summer sizzle in the stock market! Dive into the performances of Bancorp Inc, Xylem, Vertex Pharma,, and Novo Nordisk. Invest smartly.


7/3/20232 min read

Hello folks, it's that time again when we gather round the virtual campfire of the stock market, roast some smoky financial data, and crack open a cold can of juicy investment insight. Let's dive into the stocks that have our keyboards clicking this summer!

Bancorp Inc (NASDAQ: TBBK) - The Unstoppable Money Machine

Bancorp Inc has been sending shockwaves through NASDAQ with some serious earnings growth. Their EPS, the profit divvied up per stock, grew by a hulkish 76% in the last quarter. That's right, folks, Bancorp has been flexing an average growth rate of 47.6% over the last three quarters. It's not a flash in the pan either. This is their fourth year of consistent annual growth with a forecast of 59% growth this year. Just remember to keep breathing. This fitness isn't limited to earnings, as they're also boasting a 43% pre-tax margin and an ROE of 19.3%. The cherry on top? Bancorp's stock is currently a bargain at $32.65.

Xylem Inc (NYSE: XYL) - Quench Your Thirst for Growth

If you've been looking for a stock that's just bursting at the seams with growth potential, Xylem Inc is serving up just the refreshing gulp you need. With a strong EPS growth rate of 53% in the last quarter and an average of 41.5% over the last three, Xylem is like a well-hydrated plant in the stock market garden. Currently trading at $112.62, Xylem may have wilted a bit from its 52-week high, but it's still looking healthy above its 50-day moving average.

Vertex Pharmaceuticals (NASDAQ: VRTX) - Brewing Up a Biopharma Storm

Here's a prescription for your investment portfolio. Vertex Pharmaceuticals is due to report an EPS growth of 14% on August 3, 2023. Yes, there was a little setback last quarter, but with an overall growth rate of 8.5% in the last three quarters and a three-year growth rate of 25%, Vertex is still looking healthy. Trading at $351.91, Vertex's stock is just 1% shy of its 52-week high. (NASDAQ: TCOM) - Buckle Up for a Wild Ride

Your financial journey with might feel a bit like a roller coaster. Hold onto your seats as their EPS is estimated to skyrocket by a mind-boggling 456% this quarter! The company, trading at $35.00 a share, might be 13% off its 52-week high, but it's certainly got potential. If the thrill of dramatic growth isn't enough, has also seen a 107% increase in sales in the last quarter!

Novo Nordisk A/S (NYSE: NVO) - Sugarcoating Not Required

Wrapping up our roundup is Novo Nordisk, a name thatโ€™s been sweetening portfolios. They've seen an EPS growth of 38% in the last quarter, marking their third straight quarter of growth. Talk about consistency! They've also grown their sales by 24% in the last quarter. Trading slightly below its 50-day moving average at $161.83, it might just be the right time to grab a piece of the Novo Nordisk pie!

Well, that's it, folks! Remember, the stock market is like a soap opera โ€“ there's always drama, but with a little research and a lot of patience, you might just end up as the star of the show. Stay tuned, stay invested, and most importantly, stay savvy. Until next time!

Top 5 Stocks & Strategy for 2023 | AI Stock Shepherd - July 3, 2023

Join Lee, your AI Stock Shepherd, as he shares the top 5 stocks and a profitable 'Ten-Twenty-Ten' strategy for 2023. Don't forget to like, subscribe, and turn on notifications for weekly market insights. #Investing #Stocks #HighReturns